Cheryl Ho - Concepedia

Author

Cheryl Ho

BC Cancer Agency ORCID

Also Known As

C Ho, C. Ho, C.K. Ho, Chao Chi Ho, Cheng-Wei Ho, Cheryl Ho, Chia Jung Ho, Chiao Hao Ho, Chung-Man James Ho, Habib Zaidi

280

Publications

3.6K

Citations

H-Index

106

Concepts

All Affiliations

BC Cancer Agency University of British Columbia Ottawa Hospital Canada's Michael Smith Genome Sciences Centre University of Toronto

About

Cheryl Ho is an author at BC Cancer Agency specializing in medicine, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	22	32	1.4K
2	Health Sciences	6	6	360
3	Nursing	3	3	148
4	Public Health	3	3	73
5	Engineering	2	2	141

Cheryl Ho

Publications

2.9K

Citations

H-Index

Page 1

	Year	Citations
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1–Selected Advanced Non–Small-Cell Lung Cancer (BIRCH) Solange Peters, Scott Gettinger, Melissa L. Johnson, Journal of Clinical Oncology	2017	415
Randomized, Double-Blind Trial of Carboplatin and Paclitaxel With Either Daily Oral Cediranib or Placebo in Advanced Non–Small-Cell Lung Cancer: NCIC Clinical Trials Group BR24 Study Glenwood Goss, Andrew Arnold, Frances A. Shepherd, Journal of Clinical Oncology Advanced NsclcMedicinePhase IiiPharmacologyClinical Trials	2009	243
EGFR mutation status on brain metastases from non-small cell lung cancer Fred Hsu, Alex De Caluwé, David W. Anderson, Lung Cancer Neuro-oncologyBrain MetastasesPathologyCancer GenomicsCancer Genetics	2016	133
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results Valsamo Anagnostou, Cheryl Ho, Garth Nicholas, Nature Medicine	2023	125
Lessons learned from the application of whole-genome analysis to the treatment of patients with advanced cancers Janessa Laskin, Steven J.M. Jones, Samuel Aparício, Molecular Case Studies EngineeringPathologyMultiomicsCancer RegistrationTumor Biology	2015	112
Successful targeting of the NRG1 pathway indicates novel treatment strategy for metastatic cancer Martin Jones, Howard J. Lim, Yaoqing Shen, Annals of Oncology Novel Treatment StrategyMedicineNrg1 PathwayImmune Checkpoint InhibitorCancer Biology	2017	105
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial Anthony T.�C. Chan, V.H.F. Lee, R-L. Hong, Annals of Oncology	2022	100
Pan Canadian Rash Trial: A Randomized Phase III Trial Evaluating the Impact of a Prophylactic Skin Treatment Regimen on Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor–Induced Skin Toxicities in Patients With Metastatic Lung Cancer Barbara Melosky, Helén Anderson, Ronald L. Burkes, Journal of Clinical Oncology	2015	91
Emotional distress and psychosocial needs in patients with breast cancer in British Columbia: younger versus older adults Hiten Naik, Bonnie Leung, Janessa Laskin, Breast Cancer Research and Treatment NursingQuality Of LifePsychosocial ResearchBritish ColumbiaSocial Stress	2019	87
A novel P<sub>2</sub>‐purinoceptor expressed by a subpopulation of astrocytes from the dorsal spinal cord of the rat Cheryl Ho, Janice L. Hicks, Michael W. Salter British Journal of Pharmacology	1995	72

Page 1